Personensuche

Personensuche

Bitte geben Sie den Namen der gesuchten Person ein.

Es wurde 1 Person gefunden.

PD Dr. med. Marcel Wiesweg

Die folgenden Publikationen sind in der Online-Universitätsbibliographie der Universität Duisburg-Essen verzeichnet. Weitere Informationen finden Sie gegebenenfalls auch auf den persönlichen Webseiten der Person.

    Artikel in Zeitschriften

  • Wiesweg, Marcel; Küter, Claudia; Schnorbach, Johannes; Keyl, Julius; Metzenmacher, Martin; Cvetkovic, Jelena; Saalfeld, Felix Carl; Glanemann, Franziska; Eberhardt, Wilfried; Özkan, Filiz; Theegarten, Dirk; Stenzinger, Albrecht; Darwiche, Kaid; Koschel, Dirk; Herth, Felix; Bölükbas, Servet; Winter, Hauke; Weykamp, Fabian; Wermke, Martin; Stuschke, Martin; Plönes, Till; Thomas, Michael; Schuler, Martin; Christopoulos, Petros
    Oligometastatic non-small cell lung cancer : Impact of local and contemporary systemic treatment approaches on clinical outcome
    In: International Journal of Cancer Jg. 156 (2025) Nr. 4, S. 776 - 787
    Online Volltext: dx.doi.org/ (Open Access)
  • Richlitzki, Cedric; Wiesweg, Marcel; Metzenmacher, Martin; Guberina, Nika; Pöttgen, Christoph; Hautzel, Hubertus; Eberhardt, Wilfried E. E.; Darwiche, Kaid; Theegarten, Dirk; Aigner, Clemens; Bölükbas, Servet; Schuler, Martin; Stuschke, Martin; Guberina, Maja
    C-reactive protein as robust laboratory value associated with prognosis in patients with stage III non-small cell lung cancer (NSCLC) treated with definitive radiochemotherapy
    In: Scientific Reports Jg. 14 (2024) Nr. 1, 13765
    Online Volltext: dx.doi.org/ (Open Access)
  • Zaun, Gregor; Borchert, Sabrina; Metzenmacher, Martin; Lueong, Smiths; Wiesweg, Marcel; Zaun, Yasmin; Pogorzelski, Michael; Behrens, Franziska; Schildhaus, Hans-Ulrich; Virchow, Isabel; Kasper, Stefan; Schuler, Martin; Theurer, Sarah; Liffers, Sven
    Comprehensive biomarker diagnostics of unfavorable cancer of unknown primary to identify patients eligible for precision medical therapies
    In: European Journal of Cancer (EJC) Jg. 200 (2024) 113540
    Online Volltext: dx.doi.org/ (Open Access)
  • Kron, Anna; Scheffler, Matthias; Wiesweg, Marcel; Hummel, Horst-Dieter; Kulhavy, Jonas; Gatteloehner, Stefan; Kollmeier, Jens; Schubart, Christoph; Groß, Thorben; Demes, Melanie-Christin; Keymel, Stefanie; Joosten, Maria; Merkelbach-Bruse, Sabine; Woelwer, Christina Bianca; Tufman, Amanda; Kauffmann-Guerrero, Diego; Oeser, Katharina; Zehaczek, Melanie; Jeratsch, Ulli; Wolf, Juergen
    Corrigendum to “Indirect comparison of capmatinib treatment from GEOMETRY mono-1 trial to SOC in German patients with locally advanced or metastatic NSCLC harboring METex14 skipping mutations”
    In: European Journal of Cancer (EJC) Jg. 213 (2024) 115074
    Online Volltext: dx.doi.org/ (Open Access)
  • Schuler, Martin; Hense, Jörg; Darwiche, Kaid; Michels, Sebastian; Hautzel, Hubertus; Kobe, Carsten; Lueong, Smiths; Metzenmacher, Martin; Herold, Thomas; Zaun, Gregor; Laue, Katharina; Drzezga, Alexander; Theegarten, Dirk; Nensa, Felix; Wolf, Jürgen; Herrmann, Ken; Wiesweg, Marcel
    Early Metabolic Response by PET Predicts Sensitivity to Next-Line Targeted Therapy in EGFR-Mutated Lung Cancer with Unknown Mechanism of Acquired Resistance
    In: Journal of Nuclear Medicine (JNM) Jg. 65 (2024) Nr. 6, S. 851 - 855
    Online Volltext: dx.doi.org/
  • Kessler, Lukas; Schwaning, Felix; Metzenmacher, Martin; Pabst, Kim; Siveke, Jens; Trajkovic-Arsic, Marija; Schaarschmidt, Benedikt; Wiesweg, Marcel; Aigner, Clemens; Plönes, Till; Darwiche, Kaid; Bölükbas, Servet; Stuschke, Martin; Umutlu, Lale; Nader, Michael; Theegarten, Dirk; Hamacher, Rainer; Eberhardt, Wilfried; Schuler, Martin; Herrmann, Ken; Fendler, Wolfgang; Hautzel, Hubertus
    Fibroblast Activation Protein-Directed Imaging Outperforms ¹⁸F-FDG PET/CT in Malignant Mesothelioma : A Prospective, Single-Center, Observational Trial
    In: Journal of Nuclear Medicine (JNM) Jg. 65 (2024) Nr. 8, S. 1188 - 1193
    Online Volltext: dx.doi.org/
  • Kron, Anna; Scheffler, Matthias; Wiesweg, Marcel; Hummel, Horst-Dieter; Kulhavy, Jonas; Gatteloehner, Stefan; Kollmeier, Jens; Schubart, Christoph; Groß, Thorben; Demes, Melanie-Christin; Keymel, Stefanie; Joosten, Maria; Merkelbach-Bruse, Sabine; Wölwer, Christina Bianca; Tufman, Amanda; Kauffmann-Guerrero, Diego; Oeser, Katharina; Zehaczek, Melanie; Jeratsch, Ulli; Wolf, Juergen
    Indirect comparison of capmatinib treatment from GEOMETRY mono-1 trial to SOC in German patients with locally advanced or metastatic NSCLC harboring METex14 skipping mutations
    In: European Journal of Cancer (EJC) Jg. 207 (2024) 114158
    Online Volltext: dx.doi.org/
  • Guberina, Maja; Pöttgen, Christoph; Guberina, Nika; Hoffmann, Christian; Wiesweg, Marcel; Richlitzki, Cedric; Metzenmacher, Martin; Aigner, Clemens; Bölükbas, Servet; Gauler, Thomas; Eberhardt, Wilfried; Forsting, Michael; Herrmann, Ken; Theegarten, Dirk; Darwiche, Kaid; Jendrossek, Verena; Stuschke, Martin; Schuler, Martin
    Long-Term Survival in Patients with Oligometastatic Non-Small Cell Lung Cancer by a Multimodality Treatment : Comparison with Stage III Disease
    In: Cancers Jg. 16 (2024) Nr. 6, 1174
    Online Volltext: dx.doi.org/ (Open Access)
  • Illini, Oliver; Saalfeld, Felix Carl; Christopoulos, Petros; Duruisseaux, Michaël; Vikström, Anders; Peled, Nir; Demedts, Ingel; Dudnik, Elizabeth; Eisert, Anna; Hashemi, Sayed M. S.; Janzic, Urska; Kian, Waleed; Mohorcic, Katja; Mohammed, Saara; Silvoniemi, Maria; Rothschild, Sacha I.; Schulz, Christian; Wesseler, Claas; Addeo, Alfredo; Armster, Karin; Itchins, Malinda; Ivanović, Marija; Kauffmann-Guerrero, Diego; Koivunen, Jussi; Kuon, Jonas; Pavlakis, Nick; Piet, Berber; Sebastian, Martin; Velthaus-Rusik, Janna-Lisa; Wannesson, Luciano; Wiesweg, Marcel; Wurm, Robert; Albers-Leischner, Corinna; Aust, Daniela E.; Janning, Melanie; Fabikan, Hannah; Herold, Sylvia; Klimova, Anna; Loges, Sonja; Sharapova, Yana; Schütz, Maret; Weinlinger, Christoph; Valipour, Arschang; Overbeck, Tobias Raphael; Griesinger, Frank; Jakopovic, Marko; Hochmair, Maximilian J.; Wermke, Martin
    Mobocertinib in Patients with EGFR Exon 20 Insertion-Positive Non-Small Cell Lung Cancer (MOON) : An International Real-World Safety and Efficacy Analysis
    In: International Journal of Molecular Sciences (IJMS) Jg. 25 (2024) Nr. 7, 3992
    Online Volltext: dx.doi.org/ (Open Access)
  • Schuler, Martin; Cuppens, Kristof; Plönes, Till; Wiesweg, Marcel; Du Pont, Bert; Hegedus, Balazs; Köster, Johannes; Mairinger, Fabian; Darwiche, Kaid; Paschen, Annette; Maes, Brigitte; Vanbockrijck, Michel; Lähnemann, David; Zhao, Fang; Hautzel, Hubertus; Theegarten, Dirk; Hartemink, Koen; Reis, Henning; Baas, Paul; Schramm, Alexander; Aigner, Clemens
    Neoadjuvant nivolumab with or without relatlimab in resectable non-small-cell lung cancer : A randomized phase 2 trial
    In: Nature Medicine Jg. 30 (2024) Nr. 6, S. 1602 - 1611
    Online Volltext: dx.doi.org/ (Open Access)
  • Bischoff, Philip; Reck, Martin; Overbeck, Tobias; Christopoulos, Petros; Rittmeyer, Achim; Lüders, Heike; Kollmeier, Jens; Kulhavy, Jonas; Kemper, Marcel; Reinmuth, Niels; Röper, Julia; Janning, Melanie; Sommer, Linna; Aguinarte, Lukas; Koch, Myriam; Wiesweg, Marcel; Wesseler, Claas; Waller, Cornelius F.; Kauffmann-Guerrero, Diego; Stenzinger, Albrecht; Stephan-Falkenau, Susann; Trautmann, Marcel; Lassmann, Silke; Tiemann, Markus; Klauschen, Frederick; Sebastian, Martin; Griesinger, Frank; Wolf, Jürgen; Loges, Sonja; Frost, Nikolaj; Hilbrandt, Moritz; Süptitz, Juliane; Grah, Christian; Velthaus, Janna-Lisa; Kopp, Hans-Georg; Schmidt, Bernd; Horter, Susanne; Keymel, Stefanie; Aydilek, Enver; Tritchkova, Guergana; Raspe, Matthias; Papić, Dražen; Florian, Stefan; Horst, David; Wild, Peter J.; Thomas, Michael; Grohé, Christian; Bleckmann, Annalen; Wermke, Martin; Hummel, Horst-Dieter; Stratmann, Jan; Schütte, Wolfgang
    Outcome of First-Line Treatment With Pembrolizumab According to KRAS/TP53 Mutational Status for Nonsquamous Programmed Death-Ligand 1–High (≥50%) NSCLC in the German National Network Genomic Medicine Lung Cancer
    In: Journal of Thoracic Oncology Jg. 19 (2024) Nr. 5, S. 803 - 817
    Online Volltext: dx.doi.org/ (Open Access)
  • Abu Sabbah, Tanja; Theurer, Sarah; Baba, Hideo Andreas; Lueong, Smiths; Rashidi Alavijeh, Jassin; Hilser, Thomas; Zaun, Yasmin; Metzenmacher, Martin; Pogorzelski, Michael; Virchow, Isabel; Pretzell, Ina; Kostbade, Karina; Treckmann, Jürgen; Wiesweg, Marcel; Schuler, Martin; Kasper, Stefan; Zaun, Gregor
    PD-L1 expression associates with favorable survival of patients with cancer of unknown primary (CUP) not treated with checkpoint inhibitors
    In: European Journal of Cancer (EJC) Jg. 210 (2024) 114268
    Online Volltext: dx.doi.org/ (Open Access)
  • Saalfeld, Felix Carl; Möller, Johanna; Christopoulos, Petros; Wenzel, Carina; Rasokat, Anna; Wang, Xuejun Alice; Vathiotis, Ioannis; König, David; Illini, Oliver; Grohé, Christian; Wiesweg, Marcel; Wesseler, Claas; Schubart, Christoph; Pelusi, Natalie; Rohde, Gernot; Overbeck, Tobias R.; Kirfel, Jutta; Alt, Jürgen; Kauffmann-Guerrero, Diego; Griesinger, Frank; Kulhavy, Jonas; Allgäuer, Michael; Klimova, Anna; Schütz, Maret; Aust, Daniela E.; Hochmair, Maximilian J.; Rothschild, Sacha I.; Syrigos, Konstantinos N.; Veluswamy, Rajwanth; Michels, Sebastian; Stenzinger, Albrecht; Jöhrens, Korinna; Wermke, Martin
    Small cell transformation in EGFR-mutated non-small cell lung cancer : DLL3 expression and efficacy of immune checkpoint inhibitors or tyrosine kinase inhibitors combined with chemotherapy
    In: European Journal of Cancer (EJC) Jg. 213 (2024) 115065
    Online Volltext: dx.doi.org/ (Open Access)
  • Mavroeidi, Ilektra Antonia; Romanowicz, Anna; Haake, Tristan; Wienker, Johannes; Metzenmacher, Martin; Darwiche, Kaid; Oezkan, Filiz; Bölükbas, Servet; Stuschke, Martin; Umutlu, Lale; Opitz, Marcel; Nader, Michael; Hamacher, Rainer; Siveke, Jens; Winantea, Jane; Fendler, Wolfgang; Wiesweg, Marcel; Eberhardt, Wilfried; Herrmann, Ken; Theegarten, Dirk; Schuler, Martin; Hautzel, Hubertus; Kersting, David
    Theranostics with somatostatin receptor antagonists in SCLC : Correlation of 68Ga-SSO120 PET with immunohistochemistry and survival
    In: Theranostics Jg. 14 (2024) Nr. 14, S. 5400 - 5412
    Online Volltext: dx.doi.org/ (Open Access)
  • Glanemann, Franziska; Wiesweg, Marcel
    Zielgerichtete Therapie des nichtkleinzelligen Lungenkarzinoms
    In: Die Onkologie Jg. 30 (2024) Nr. 9, S. 877 - 885
    Online Volltext: dx.doi.org/
  • Kersting, David; Sandach, Patrick; Sraieb, Miriam; Wiesweg, Marcel; Metzenmacher, Martin; Darwiche, Kaid; Oezkan, Filiz; Bölükbas, Servet; Stuschke, Martin; Umutlu, Lale; Nader, Michael; Hamacher, Rainer; Fendler, Wolfgang; Wienker, Johannes; Eberhardt, Wilfried; Schuler, Martin; Herrmann, Ken; Hautzel, Hubertus
    68Ga-SSO-120 PET for Initial Staging of Small Cell Lung Cancer Patients : A Single-Center Retrospective Study
    In: Journal of Nuclear Medicine (JNM) Jg. 64 (2023) Nr. 10, S. 1540 - 1549
    Online Volltext: dx.doi.org/ (Open Access)
  • Virchow, Isabel; Treckmann, Jürgen-Walter; Prasnikar, Nicole; Linden, Gabriele; Markus, Peter; Schumacher, Brigitte; Albers, David; Herold, Thomas; Ting, Saskia; Schmidt, Hartmut; Radunz, Sonja; Wiesweg, Marcel; Siveke, Jens; Schuler, Martin; Kasper, Stefan
    A Phase II Study of Nab-Paclitaxel and Gemcitabine as First-Line Therapy in Patients with Cholangiocarcinoma Ineligible for Cisplatin-Based Chemotherapy (NACHO)
    In: Oncology Research and Treatment Jg. 46 (2023) Nr. 3, S. 89 - 99
    Online Volltext: dx.doi.org/ (Open Access)
  • Maßmann, M.; Treckmann, Jürgen Walter; Markus, P.; Schumacher, B.; Albers, D.; Ting, Saskia; Mende, B.; Roehrle, J.; Virchow, I.; Rosery, V.; Laue, K.; Zaun, G.; Kostbade, K.; Pogorzelski, M.; Schmid, Kurt Werner; Baba, Hideo Andreas; Siveke, Jens; Paul, A.; Schildhaus, Hans-Ulrich; Schuler, Martin; Wiesweg, Marcel; Kasper, Stefan
    A prognostic systemic inflammation score (SIS) in patients with advanced intrahepatic cholangiocarcinoma
    In: Journal of Cancer Research and Clinical Oncology Jg. 149 (2023) Nr. 8, S. 5085 - 5094
    Online Volltext: dx.doi.org/ (Open Access)
  • Roehrle, Julius; Kasper, Stefan; Treckmann, Jürgen-Walter; Markus, Peter; Schumacher, Brigitte; Albers, David; Wendling, Johanna; Ting, Saskia; Mende, Bastian; Maßmann, Marlene; Markus, Maximilian; Virchow, Isabel; Rosery, Vivian; Laue, Katharina; Zaun, Gregor; Kostbade, Karina; Pogorzelski, Michael; Reissig, Timm M.; Liffers, Sven-Thorsten; Schmid, Kurt Werner; Schildhaus, Hans-Ulrich; Schuler, Martin; Siveke, Jens; Wiesweg, Marcel
    Clinical Outcome and Treatment Sequences of Patients with Advanced Pancreatic Cancer Treated with Contemporary Chemotherapy Protocols
    In: Oncology Research and Treatment Jg. 46 (2023) Nr. 4, S. 140 - 150
    Online Volltext: dx.doi.org/
  • Keyl, Julius; Hosch, René; Berger, Aaron; Ester, Oliver; Greiner, Tobias; Bogner, Simon; Treckmann, Jürgen; Ting, Saskia; Schumacher, Brigitte; Albers, David; Markus, Peter; Wiesweg, Marcel; Forsting, Michael; Nensa, Felix; Schuler, Martin; Kasper, Stefan; Kleesiek, Jens
    Deep learning-based assessment of body composition and liver tumour burden for survival modelling in advanced colorectal cancer
    In: Journal of Cachexia, Sarcopenia and Muscle Jg. 14 (2023) Nr. 1, S. 545 - 552
    Online Volltext: dx.doi.org/ Online Volltext (Open Access)
  • Warnecke, Eva; Salvador Comino, Maria Rosa; Kocol, Dilara; Hosters, Bernadette; Wiesweg, Marcel; Bauer, Sebastian; Welt, Anja; Heinzelmann, Anna; Müller, Sandy; Schuler, Martin; Teufel, Martin; Tewes, Mitra
    Electronic Patient-Reported Outcome Measures (ePROMs) Improve the Assessment of Underrated Physical and Psychological Symptom Burden among Oncological Inpatients
    In: Cancers Jg. 15 (2023) Nr. 11, 3029
    Online Volltext: dx.doi.org/ Online Volltext (Open Access)
  • Kraskowski, Oliver; Stratmann, Jan A.; Wiesweg, Marcel; Eberhardt, Wilfried; Metzenmacher, Martin; Schmid, Kurt Werner; Herold, Thomas; Schildhaus, Hans-Ulrich; Darwiche, Kaid; Aigner, Clemens; Stuschke, Martin; Laue, Katharina; Zaun, Gregor; Kasper, Stefan; Hense, Jörg; Sebastian, Martin; Schuler, Martin; Pogorzelski, Michael
    Favorable survival outcomes in epidermal growth factor receptor (EGFR)-mutant non-small cell lung cancer sequentially treated with a tyrosine kinase inhibitor and osimertinib in a real-world setting
    In: Journal of Cancer Research and Clinical Oncology Jg. 149 (2023) Nr. 11, S. 9243 - 9252
    Online Volltext: dx.doi.org/ (Open Access)
  • Rosery, Vivian; Mika, Stephan; Schmid, Kurt Werner; Reis, Henning; Stuschke, Martin; Treckmann, Jürgen; Markus, Peter; Schumacher, Brigitte; Albers, David; Mende, Bastian; Lahner, Harald; Wiesweg, Marcel; Schuler, Martin; Siveke, Jens; Kasper, Stefan
    Identification of a new prognostic score for patients with high-grade metastatic GEP-NEN treated with palliative chemotherapy
    In: Journal of Cancer Research and Clinical Oncology Jg. 149 (2023) Nr. 8, S. 4315 - 4325
    Online Volltext: dx.doi.org/ (Open Access)
  • Zurloh, M.; Goetz, M.; Herold, T.; Treckmann, Jürgen-Walter; Markus, P.; Schumacher, B.; Albers, D.; Rink, A.; Rosery, V.; Zaun, G.; Kostbade, K.; Pogorzelski, M.; Ting, S.; Schmidt, H.; Stiens, R.; Wiesweg, Marcel; Schuler, Martin; Kasper, Stefan; Virchow, I.
    Impact of encorafenib on survival of patients with BRAFV⁶⁰⁰E-mutant metastatic colorectal cancer in a real-world setting
    In: Journal of Cancer Research and Clinical Oncology Jg. 149 (2023) Nr. 14, S. 12903 - 12912
    Online Volltext: dx.doi.org/ (Open Access)
  • Zaun, Gregor; Weber, Manuel; Metzenmacher, Martin; Wiesweg, Marcel; Hilser, Thomas; Zaun, Yasmin; Liffers, Sven; Pogorzelski, Michael; Virchow, Isabel; Eberhardt, Wilfried; Theurer, Sarah; Sabbah, Tanja Abu; Reissig, Timm M.; Stuschke, Martin; Kürten, Cornelius; Hussain, Timon; Lang, Stephan; Kasper, Stefan; Fendler, Wolfgang; Herrmann, Ken; Schuler, Martin
    SUVmₐₓ Above 20 in ¹⁸F-FDG PET/CT at Initial Diagnostic Workup Associates with Favorable Survival in Patients with Cancer of Unknown Primary
    In: Journal of Nuclear Medicine (JNM) Jg. 64 (2023) Nr. 8, S. 1191 - 1194
    Online Volltext: dx.doi.org/ (Open Access)
  • Reissig, T.M.; Tzianopoulos, I.; Liffers, S.-T.; Rosery, V.K.; Guyot, M.; Ting, S.; Wiesweg, Marcel; Kasper, S.; Meister, P.; Herold, T.; Schmidt, H.H.; Schumacher, B.; Albers, David; Markus, P.; Treckmann, J.; Schuler, Martin; Schildhaus, Hans-Ulrich; Siveke, Jens
    Smaller panel, similar results : Genomic profiling and molecularly informed therapy in pancreatic cancer
    In: ESMO Open Jg. 8 (2023) Nr. 3, 101539
    Online Volltext: dx.doi.org/ (Open Access)
  • Wessolly, Michael; Stephan-Falkenau, Susann; Streubel, Anna; Wiesweg, Marcel; Borchert, Sabrina; Mairinger, Elena; Kollmeier, Jens; Reis, Henning; Bauer, Torsten; Schmid, Kurt Werner; Mairinger, Thomas; Schuler, Martin; Mairinger, Fabian D.
    Digital gene expression analysis of NSCLC-patients reveals strong immune pressure, resulting in an immune escape under immunotherapy
    In: BMC Cancer Jg. 22 (2022) Nr. 1, 46
    Online Volltext: dx.doi.org/ Online Volltext (Open Access)
  • Guberina, Maja; Guberina, Nika; Pöttgen, Christoph; Gauler, Thomas; Richlitzki, Cedric; Metzenmacher, Martin; Wiesweg, Marcel; Plönes, Till; Forsting, Michael; Wetter, Axel; Herrmann, Ken; Hautzel, Hubertus; Darwiche, Kaid; Theegarten, Dirk; Aigner, Clemens; Schuler, Martin; Stuschke, Martin; Eberhardt, Wilfried
    Effectiveness of durvalumab consolidation in stage III non-small-cell lung cancer : focus on treatment selection and prognostic factors
    In: Immunotherapy Jg. 14 (2022) Nr. 12, S. 927 - 944
    Online Volltext: dx.doi.org/ (Open Access)
  • Albers, David; Schmidt, Arthur; Schiemer, Moritz; Caca, Karel; Wannhoff, Andreas; Sauer, Peter; Wiesweg, Marcel; Schumacher, Brigitte; Dechene, Alexander
    Impact of endobiliary radiofrequency ablation on biliary drainage in patients with malignant biliary strictures treated with uncovered self-expandable metal stents : A randomized controlled multicenter trial
    In: Gastrointestinal Endoscopy Jg. 96 (2022) Nr. 6, S. 970 - 979
    Online Volltext: dx.doi.org/
  • Keyl, J.; Kasper, S.; Wiesweg, Marcel; Götze, J.; Schönrock, M.; Sinn, M.; Berger, A.; Nasca, E.; Kostbade, K.; Schumacher, B.; Markus, P.; Treckmann, Jürgen-Walter; Schmid, Kurt Werner; Schildhaus, Hans-Ulrich; Siveke, Jens; Schuler, Martin; Kleesiek, J.
    Multimodal survival prediction in advanced pancreatic cancer using machine learning
    In: ESMO Open Jg. 7 (2022) Nr. 5, 100555
    Online Volltext: dx.doi.org/ Online Volltext (Open Access)
  • Guberina, Maja; Herrmann, Ken; Pöttgen, Christoph; Guberina, Nika; Hautzel, Hubertus; Gauler, Thomas; Ploenes, Till; Umutlu, Lale; Wetter, Axel; Theegarten, Dirk; Aigner, Clemens; Eberhardt, Wilfried; Metzenmacher, Martin; Wiesweg, Marcel; Schuler, Martin; Karpf-Wissel, Rüdiger; Santiago Garcia, Alina; Darwiche, Kaid; Stuschke, Martin
    Prediction of malignant lymph nodes in NSCLC by machine-learning classifiers using EBUS-TBNA and PET/CT
    In: Scientific Reports Jg. 12 (2022) Nr. 1, 17511
    Online Volltext: dx.doi.org/ Online Volltext (Open Access)
  • Scheffler, Matthias; Wiesweg, Marcel; Michels, Sebastian; Nogová, Lucia; Kron, Anna; Herold, Thomas; Scheel, Andreas H.; Metzenmacher, Martin; Eberhardt, Wilfried; Reis, Henning; Fassunke, Jana; Darwiche, Kaid; Aigner, Clemens; Schaufler, Diana; Riedel, Richard; Fischer, Rieke; Koleczko, Sophia; Schildhaus, Hans-Ulrich; Merkelbach-Bruse, Sabine; Schmid, Kurt Werner; Büttner, Reinhard; Wolf, Jürgen; Schuler, Martin
    Rebiopsy in advanced non-small cell lung cancer, clinical relevance and prognostic implications
    In: Lung Cancer Jg. 168 (2022) S. 10 - 20
    Online Volltext: dx.doi.org/
  • Wiesweg, Marcel; Eberhardt, Wilfried; Schuler, Martin; Plönes, Till
    Therapie früher und lokal fortgeschrittener Stadien des nicht-kleinzelligen Lungenkarzinoms
    In: Die Innere Medizin Jg. 63 (2022) Nr. 7, S. 717 - 723
    Online Volltext: dx.doi.org/
  • Janning, M.; Süptitz, J.; Albers-Leischner, C.; Delpy, P.; Tufman, A.; Velthaus-Rusik, J.-L.; Reck, M.; Jung, A.; Kauffmann-Guerrero, D.; Bonzheim, I.; Brändlein, S.; Hummel, H.-D.; Wiesweg, Marcel; Schildhaus, Hans-Ulrich; Stratmann, J.A.; Sebastian, M.; Alt, J.; Buth, J.; Esposito, I.; Berger, J.; Tögel, L.; Saalfeld, F.C.; Wermke, M.; Merkelbach-Bruse, S.; Hillmer, A.M.; Klauschen, F.; Bokemeyer, C.; Buettner, R.; Wolf, J.; Loges, S.; Simon, Ronald; Sauter, Guido; Volk, Alexander; Neumann, Jens; Weichert, Wilko; Kalhori, Naser; Lüthen, Reinhard; Stöhr, Robert; Schubart, Chistoph; Wacker, Heidemarie; Fuchs, Florian; Hartmann, Nils; Graf, Stefanie; Brandts, Christian; Wild, Peter; Demes, Melanie; Reis, Henning; Rohde, Gernot
    Treatment outcome of atypical EGFR mutations in the German National Network Genomic Medicine Lung Cancer (nNGM)
    In: Annals of Oncology Jg. 33 (2022) Nr. 6, S. 602 - 615
    Online Volltext: dx.doi.org/ (Open Access)
  • Metzenmacher, Martin; Goetz, Moritz; Herold, Thomas; Stuschke, Martin; Aigner, Clemens; Darwiche, Kaid; Eberhardt, Wilfried; Schuler, Martin; Wiesweg, Marcel
    Acquired Resistance to BRAF/MEK Inhibitor Therapy in BRAF-V⁶⁰⁰-mutated Squamous Cell Lung Cancer : Concurrent Evolvement of PTEN and MEK1 Mutations
    In: Clinical Lung Cancer Jg. 22 (2021) Nr. 5, S. E668 - E672
    Online Volltext: dx.doi.org/
  • Wiesweg, Marcel; Preuß, Cedric; Roeper, Julia; Metzenmacher, Martin; Eberhardt, Wilfried; Stropiep, Ursula; Wedeken, Katrin; Reis, Henning; Herold, Thomas; Darwiche, Kaid; Aigner, Clemens; Stuschke, Martin; Schildhaus, Hans-Ulrich; Schmid, Kurt Werner; Falk, Markus; Heukamp, Lukas; Tiemann, Markus; Griesinger, Frank; Schuler, Martin
    BRAF mutations and BRAF mutation functional class have no negative impact on the clinical outcome of advanced NSCLC and associate with susceptibility to immunotherapy
    In: European Journal of Cancer (EJC) Jg. 149 (2021) S. 211 - 221
    Online Volltext: dx.doi.org/
  • Markus, M.; Abendroth, Annalena; Noureddine, R.; Paul, Andreas; Breitenbuecher, Sandra; Virchow, Isabel; Schmid, Kurt Werner; Markus, Peter; Schumacher, Brigitte M.; Wiesweg, Marcel; Wendling, Johanna; Mende, Bastian; Siveke, Jens; Schuler, Martin; Kasper, Stefan
    Combined systemic inflammation score (SIS) correlates with prognosis in patients with advanced pancreatic cancer receiving palliative chemotherapy
    In: Journal of Cancer Research and Clinical Oncology Jg. 147 (2021) Nr. 2, S. 579 - 591
    Online Volltext: dx.doi.org/ (Open Access)
  • Schotten, Lea M.; Darwiche, Kaid; Seweryn, Michal; Yildiz, Vedat; Kneuertz, Peter J.; Eberhardt, Wilfried; Eisenmann, Stephan; Welter, Stefan; Sisson, Brianna E.; Pietrzak, Maciej; Wiesweg, Marcel; Plönes, Till; Hager, Thomas; He, Kai; Freitag, Lutz; Aigner, Clemens; Taube, Christian; Oezkan, Filiz
    DNA methylation of PTGER4 in peripheral blood plasma helps to distinguish between lung cancer, benign pulmonary nodules and chronic obstructive pulmonary disease patients
    In: European Journal of Cancer (EJC) Jg. 147 (2021) S. 142 - 150
    Online Volltext: dx.doi.org/
  • Saalfeld, Felix C.; Wenzel, Carina; Christopoulos, Petros; Merkelbach-Bruse, Sabine; Reissig, Timm M.; Laßmann, Silke; Thiel, Sebastian; Stratmann, Jan A.; Marienfeld, Ralf; Berger, Johannes; Desuki, Alexander; Velthaus, Janna-Lisa; Kauffmann-Guerrero, Diego; Stenzinger, Albrecht; Michels, Sebastian; Herold, Thomas; Kramer, Michael; Herold, Sylvia; Tufman, Amanda; Loges, Sonja; Alt, Jürgen; Joosten, Maria; Schmidtke-Schrezenmeier, Gerlinde; Sebastian, Martin; Stephan-Falkenau, Susann; Waller, Cornelius F.; Wiesweg, Marcel; Wolf, Jürgen; Thomas, Michael; Aust, Daniela E.; Wermke, Martin
    Efficacy of Immune Checkpoint Inhibitors Alone or in Combination With Chemotherapy in NSCLC Harboring ERBB2 Mutations
    In: Journal of Thoracic Oncology Jg. 16 (2021) Nr. 11, S. 1952 - 1958
    Online Volltext: dx.doi.org/ (Open Access)
  • Ho, Cassandra S. L.; Tüns, Alicia I.; Schildhaus, Hans-Ulrich; Wiesweg, Marcel; Grüner, Barbara M.; Hegedus, Balazs; Schuler, Martin; Schramm, Alexander; Oeck, Sebastian
    HER2 mediates clinical resistance to the KRASG¹²C inhibitor sotorasib, which is overcome by co-targeting SHP2
    In: European Journal of Cancer (EJC) Jg. 159 (2021) S. 16 - 23
    Online Volltext: dx.doi.org/
  • Guberina, Maja; Darwiche, Kaid; Hautzel, Hubertus; Pöttgen, Christoph; Guberina, Nika; Gauler, Thomas; Ploenes, Till; Umutlu, Lale; Theegarten, Dirk; Aigner, Clemens; Eberhardt, Wilfried; Metzenmacher, Martin; Wiesweg, Marcel; Karpf-Wissel, Rüdiger; Schuler, Martin; Herrmann, Ken; Stuschke, Martin
    Patterns of nodal spread in stage III NSCLC : Importance of EBUS-TBNA and ¹⁸F-FDG PET/CT for radiotherapy target volume definition
    In: Radiation Oncology Jg. 16 (2021) Nr. 1, 176
    Online Volltext: dx.doi.org/ Online Volltext (Open Access)
  • Guberina, Maja; Pöttgen, Christoph; Metzenmacher, Martin; Wiesweg, Marcel; Schuler, Martin; Aigner, Clemens; Ploenes, Till; Umutlu, Lale; Gauler, Thomas; Darwiche, Kaid; Stamatis, Georgios; Theegarten, Dirk; Hautzel, Hubertus; Jentzen, Walter; Guberina, Nika; Herrmann, Ken; Eberhardt, Wilfried E.E.; Stuschke, Martin
    Prognostic Value of Postinduction Chemotherapy Volumetric PET/CT Parameters for Stage IIIA or IIIB Non-Small Cell Lung Cancer Patients Receiving Definitive Chemoradiotherapy
    In: Journal of Nuclear Medicine (JNM) Jg. 62 (2021) Nr. 12, S. 1684 - 1691
    Online Volltext: dx.doi.org/ Online Volltext (Open Access)
  • Kasper, Stefan; Meiler, Johannes; Knipp, Heike; Höhler, Thomas; Reimer, Peter; Steinmetz, Tilman; Berger, Winfried; Linden, Gabriele; Reis, Henning; Markus, Peter; Paul, Andreas; Dechene, Alexander; Schumacher, Brigitte; Kostbade, Karina; Virchow, Isabel; Ting, Saskia; Worm, Karl; Schmid, Kurt Werner; Herold, Thomas; Wiesweg, Marcel; Schuler, Martin; Trarbach, Tanja
    Biweekly Cetuximab Plus FOLFOX6 as First-Line Therapy in Patients With RAS Wild-Type Metastatic Colorectal Cancer : The CEBIFOX Trial
    In: Clinical Colorectal Cancer Jg. 19 (2020) Nr. 4, S. 236 - 247.e6
    Online Volltext: dx.doi.org/
  • Welt, Anja; Wiesweg, Marcel; Theurer, Sarah; Abenhardt, Wolfgang; Groschek, Matthias; Müller, Lothar; Schröder, Jan; Tewes, Mitra; Chiabudini, Marco; Potthoff, Karin; Bankfalvi, Agnes; Marschner, Norbert; Schuler, Martin; Breitenbücher, Frank
    Buparlisib in combination with tamoxifen in pretreated patients with hormone receptor-positive, HER2-negative advanced breast cancer molecularly stratified for PIK3CA mutations and loss of PTEN expression
    In: Cancer Medicine Jg. 9 (2020) Nr. 13, S. 4527 - 4539
    Online Volltext: dx.doi.org/ Online Volltext (Open Access)
  • Wiesweg, Marcel; Herold, Thomas; Metzenmacher, Martin; Eberhardt, Wilfried; Reis, Henning; Darwiche, Kaid; Aigner, Clemens; Stuschke, Martin; Herrmann, Ken; Nensa, Felix; Schildhaus, Hans-Ulrich; Schuler, Martin
    Clinical response to crizotinib and emergence of resistance in lung adenocarcinoma harboring a MET c-Cbl binding site mutation
    In: Lung Cancer Jg. 139 (2020) S. 165 - 168
    Online Volltext: dx.doi.org/
  • Wiesweg, Marcel; Schuler, Martin; Schildhaus, Hans-Ulrich
    Crizotinib in ROS1 and MET deregulated NSCLC-letter
    In: Clinical Cancer Research Jg. 26 (2020) Nr. 7, S. 1774
    Online Volltext: dx.doi.org/ (Open Access)
  • Reissig, Timm M.; Sara, Linda; Ting, Saskia; Reis, Henning; Metzenmacher, Martin; Eberhardt, Wilfried; Zaun, Gregor; Herold, Thomas; Aigner, Clemens; Darwiche, Kaid; Stuschke, Martin; Schildhaus, Hans-Ulrich; Schuler, Martin; Wiesweg, Marcel
    ERK phosphorylation as a marker of RAS activity and its prognostic value in non-small cell lung cancer
    In: Lung Cancer Jg. 149 (2020) S. 10 - 16
    Online Volltext: dx.doi.org/
  • Welt, Anja; Bogner, Simon; Arendt, Marina; Kossow, Josef; Huffziger, Antonia; Pohlkamp, Christian; Steiniger, Heike; Becker, Ute; Alashkar, Ferras; Kohl, Marzena; Wiesweg, Marcel; Richly, Heike; Hense, Jörg; Scheulen, Max Ernst; Schuler, Martin; Seeber, Siegfried; Tewes, Mitra
    Improved survival in metastatic breast cancer : results from a 20-year study involving 1033 women treated at a single comprehensive cancer center
    In: Journal of Cancer Research and Clinical Oncology (2020)
    Online Volltext: dx.doi.org/ (Open Access)
  • Wiesweg, Marcel; Mairinger, Fabian; Reis, Henning; Goetz, Moritz; Kollmeier, Jens; Misch, Daniel; Stephan-Falkenau, Susann; Mairinger, Thomas; Walter, Robert F.H.; Hager, Thomas; Metzenmacher, Martin; Eberhardt, Wilfried; Zaun, Gregor; Köster, Johannes; Stuschke, Martin; Aigner, Clemens; Darwiche, Kaid; Schmid, Kurt Werner; Rahmann, Sven; Schuler, Martin
    Machine learning reveals a PD-L1–independent prediction of response to immunotherapy of non-small cell lung cancer by gene expression context
    In: European Journal of Cancer (EJC) Jg. 140 (2020) S. 76 - 85
    Online Volltext: dx.doi.org/
  • Metzenmacher, Martin; Váraljai, Renáta; Hegedüs, Balazs; Cima, Igor; Forster, Jan; Schramm, Alexander; Scheffler, Björn; Horn, Peter; Klein, Christoph A.; Szarvas, Tibor; Reis, Henning; Bielefeld, Nicola; Rösch, Alexander; Aigner, Clemens; Kunzmann, Volker; Wiesweg, Marcel; Siveke, Jens; Schuler, Martin; Lueong, Smiths S.
    Plasma next generation sequencing and droplet digital-qpcr-based quantification of circulating cell-free rna for noninvasive early detection of cancer
    In: Cancers Jg. 12 (2020) Nr. 2, S. 353
    Online Volltext: dx.doi.org/ Online Volltext (Open Access)
  • Mazières, Julien; Drilon, A.; Lusque, A.; Mhanna, L.; Cortot, A. B.; Mezquita, L.; Thai, A. A.; Mascaux, C.; Couraud, S.; Veillon, R.; Heuvel, M. van den; Neal, J.; Peled, N.; Früh, M.; Ng, T. L.; Gounant, V.; Popat, S.; Diebold, J.; Sabari, J.; Zhu, V. W.; Rothschild, S. I.; Bironzo, P.; Martinez, A.; Curioni-Fontecedro, A.; Rosell, R.; Lattuca-Truc, M.; Wiesweg, Marcel; Besse, B.; Solomon, B.; Barlesi, F.; Schouten, R. D.; Wakelee, H.; Camidge, D. R.; Zalcman, G.; Novello, S.; Ou, S. I.; Milia, J.; Gautschi, O.
    Immune checkpoint inhibitors for patients with advanced lung cancer and oncogenic driver alterations : results from the IMMUNOTARGET registry
    In: Annals of Oncology Jg. 30 (2019) Nr. 8, S. 1321 - 1328
    Online Volltext: dx.doi.org/ (Open Access)
  • Wiesweg, Marcel; Kasper, Stefan; Worm, Karl; Herold, Thomas; Reis, Henning; Sara, Linda; Metzenmacher, Martin; Abendroth, Annalena; Darwiche, Kaid; Aigner, Clemens; Wedemeyer, Heiner; Helfritz, Fabian A.; Stuschke, Martin; Schumacher, Brigitte; Markus, Peter; Paul, Andreas; Rahmann, Sven; Schmid, Kurt Werner; Schuler, Martin
    Impact of RAS mutation subtype on clinical outcome : A cross-entity comparison of patients with advanced non-small cell lung cancer and colorectal cancer
    In: Oncogene Jg. 38 (2019) Nr. 16, S. 2953 - 2966
    Online Volltext: dx.doi.org/
  • Abendroth, A.; Noureddine, R.; Abramczyk, M.; Paul, Andreas; Gerken, Guido; Schmid, Kurt Werner; Markus, P.; Schumacher, B.; Wiesweg, Marcel; Köhler, Jens; Markus, M.; Mende, B.; Dechene, Alexander; Schuler, Martin; Kasper, Stefan
    Long-term outcome of patients with advanced pancreatic cancer treated with sequential chemotherapies before the era of modern combination therapy protocols
    In: Journal of Cancer Research and Clinical Oncology Jg. 145 (2019) Nr. 2, S. 445 - 455
    Online Volltext: dx.doi.org/
  • Wiesweg, Marcel; Mairinger, Fabian; Reis, Henning; Goetz, Moritz; Walter, Robert; Hager, Thomas; Metzenmacher, Martin; Eberhardt, Wilfried; McCutcheon, A.; Köster, J.; Stuschke, Martin; Aigner, Clemens; Darwiche, Kaid; Schmid, Kurt Werner; Rahmann, Sven; Schuler, Martin
    Machine learning-based predictors for immune checkpoint inhibitor therapy of non-small-cell lung cancer
    In: Annals of Oncology Jg. 30 (2019) Nr. 4, S. 655 - 657
    Online Volltext: dx.doi.org/ (Open Access)
  • Gautschi, O.; Drilon, A.; Milia, J.; Lusque, A.; Mhanna, L.; Li, B.; Sabari, J.; Cortot, A.; Besse, B.; Mezquita, L.; Solomon, B.; Thai, A.; Couraud, S.; Veilion, R.; Mascaux, C.; Barlesi, F.; Van den Heuvel, M.; Schouten, R.; Wakelee, H.; Mah, A.; Camidge, D. R.; Ng, T.; Peled, N.; Lilach, Y.; Popat, S.; Ou, S.; Zhu, V.; Velcheti, V.; Fontecedro, A. C.; Akhoundova, D.; Fruh, M.; Zalcman, G.; Gounant, V.; Novello, S.; Bironzo, P.; Felip, E.; Martinez-Marti, A.; Moro-Sibilot, D.; Rosell, R.; Karachaliou, N.; Schuler, Martin; Wiesweg, Marcel; Diebold, J.; Mazieres, J.
    Immunotherapy for Non-Small Cell Lung Cancers (NSCLC) with Oncogenic Driver Mutations : New Results from the Global IMMUNOTARGET Registry
    In: Journal of Thoracic Oncology Jg. 13 (2018) Nr. Suppl. 10, S. 367
    Online Volltext: dx.doi.org/ (Open Access)
  • Reis, Henning; Metzenmacher, Martin; Goetz, Moritz; Savvidou, Nikoleta; Darwiche, Kaid; Aigner, Clemens; Herold, Thomas; Eberhardt, Wilfried; Skiba, Charlotte; Hense, Jörg; Virchow, Isabel; Westerwick, Daniela; Bogner, Simon; Ting, Saskia; Kasper, Stefan; Stuschke, Martin; Nensa, Felix; Herrmann, Ken; Hager, Thomas; Schmid, Kurt Werner; Schuler, Martin; Wiesweg, Marcel
    MET Expression in Advanced Non–Small-Cell Lung Cancer : Effect on Clinical Outcomes of Chemotherapy, Targeted Therapy, and Immunotherapy
    In: Clinical Lung Cancer Jg. 19 (2018) Nr. 4, S. e441 - e463
    Online Volltext: dx.doi.org/
  • Reis, Henning; van der Vos, Kristan E.; Niedworok, Christian; Herold, Thomas; Módos, Orsolya; Szendroi, Attila; Hager, Thomas; Ingenwerth, Marc; Vis, Daniël J.; Behrendt, Mark A.; de Jong, Jeroen; van der Heijden, Michiel S.; Peyronnet, Benoit; Mathieu, Romain; Wiesweg, Marcel; Ablat, Jason; Okon, Krzysztof; Tolkach, Yuri; Keresztes, David; Nagy, Nikolett; Bremmer, Felix; Gaisa, Nadine T.; Chlosta, Piotr; Kriegsmann, Joerg; Kovalszky, Ilona; Timar, József; Kristiansen, Glen; Radzun, Heinz-Joachim; Knüchel, Ruth; Schuler, Martin; Black, Peter C.; Rübben, Herbert; Hadaschik, Boris; Schmid, Kurt Werner; van Rhijn, Bas W.G.; Nyirády, Péter; Szarvas, Tibor
    Pathogenic and targetable genetic alterations in 70 urachal adenocarcinomas
    In: International Journal of Cancer Jg. 143 (2018) Nr. 7, S. 1764 - 1773
    Online Volltext: dx.doi.org/ (Open Access)
  • Wiesweg, Marcel; Reis, Henning; Köster, Tobias; Goetz, Moritz; Worm, Karl; Herold, Thomas; Paul, Andreas; Dechene, Alexander; Schumacher, Brigitte; Markus, Peter; Virchow, Isabel; Kostbade, Karina; Wolf, Nathalie; Zaun, Gregor; Metzenmacher, Martin; Schmid, Kurt Werner; Schuler, Martin; Kasper, Stefan
    Phosphorylation of p70 Ribosomal Protein S6 Kinase β-1 is an Independent Prognostic Parameter in Metastatic Colorectal Cancer
    In: Clinical Colorectal Cancer Jg. 17 (2018) Nr. 2, S. e331 - e352
    Online Volltext: dx.doi.org/
  • Oezkan, Filiz; Herold, Thomas; Darwiche, Kaid; Eberhardt, Wilfried; Worm, Karl; Christoph, Daniel; Wiesweg, Marcel; Freitag, Lutz; Schmid, Kurt Werner; Theegarten, Dirk; Hager, Thomas; Koenig, Michael J.; He, Kai; Taube, Christian; Schuler, Martin; Breitenbücher, Frank
    Rapid and Highly Sensitive Detection of Therapeutically Relevant Oncogenic Driver Mutations in EBUS-TBNA Specimens From Patients With Lung Adenocarcinoma
    In: Clinical Lung Cancer Jg. 19 (2018) Nr. 6, S. e879 - e884
    Online Volltext: dx.doi.org/
  • Wiesweg, Marcel; Eberhardt, Wilfried; Reis, Henning; Ting, Saskia; Savvidou, Nikoleta; Skiba, Charlotte; Herold, Thomas; Christoph, Daniel; Meiler, Johannes; Worm, Karl; Kasper, Stefan; Theegarten, Dirk; Hense, Jörg; Hager, Thomas; Darwiche, Kaid; Oezkan, Filiz; Aigner, Clemens; Welter, Stefan; Kühl, Hilmar; Stuschke, Martin; Schmid, Kurt Werner; Schuler, Martin
    High Prevalence of Concomitant Oncogene Mutations in Prospectively Identified Patients with ROS1-Positive Metastatic Lung Cancer
    In: Journal of Thoracic Oncology Jg. 12 (2017) Nr. 1, S. 54 - 64
    Online Volltext: dx.doi.org/ (Open Access)
  • Kasper, Stefan; Reis, Henning; Ziegler, Sophie; Nothdurft, Silke; Mueller, Andre; Goetz, Moritz; Wiesweg, Marcel; Phasue, Jeannette; Ting, Saskia; Wieczorek, Sarah; Even, Anna; Worm, Karl; Pogorzelski, Michael; Breitenbuecher, Sandra; Meiler, Johannes; Paul, Andreas; Trarbach, Tanja; Schmid, Kurt Werner; Breitenbücher, Frank; Schuler, Martin
    Molecular dissection of effector mechanisms of RAS-mediated resistance to anti-EGFR antibody therapy
    In: OncoTarget Jg. 8 (2017) Nr. 28, S. 45898 - 45917
    Online Volltext: dx.doi.org/ (Open Access)
  • Wiesweg, Marcel; Ting, Saskia; Reis, Henning; Worm, Karl; Kasper, Stefan; Tewes, Mitra; Welt, Anja; Richly, Heike; Meiler, Johannes; Bauer, Sebastian; Hense, Jörg; Gauler, Thomas; Köhler, Jens; Eberhardt, Wilfried; Darwiche, Kaid; Freitag, Lutz; Stamatis, Georgios; Breitenbücher, Frank; Wohlschläger, Jeremias; Theegarten, Dirk; Derks, Cordula; Cortes-Incio, Diana; Linden, Gabriele; Skottky, Silke; Lütkes, Peter; Dechene, Alexander; Paul, Andreas; Markus, Peter; Schmid, Kurt Werner; Schuler, Martin
    Feasibility of preemptive biomarker profiling for personalised early clinical drug development at a Comprehensive Cancer Center
    In: European Journal of Cancer (EJC) Jg. 49 (2013) Nr. 15, S. 3076 - 3082
    Online Volltext: dx.doi.org/
  • Wiesweg, M.; Berchner-Pfannschmidt, Utta; Fandrey, Joachim; Petrat, Frank; de Groot, H.; Kirsch, Michael
    Rocket fuel for the quantification of S-nitrosothiols : highly specific reduction of S-nitrosothiols to thiols by methylhydrazine
    In: Free Radical Research Jg. 47 (2013) Nr. 2, S. 104 - 115
    Online Volltext: dx.doi.org/
  • Wiesweg, Marcel; Kasper, Stefan; Wohlschläger, Jeremias; Ting, Saskia; Skottky, S.; Worm, K.; Derks, C.; Tewes, Mitra; Breitenbücher, Frank; Gauler, Thomas; Eberhardt, Wilfried; Ahrens, M.; Hoiczyk, M.; Meiler, Johannes; Hense, Jörg; Welt, Anja; Theegarten, Dirk; Freitag, Lutz; Kimmig, Rainer; Schmid, Kurt Werner; Schuler, Martin
    VVTZ-Tumorprofil - First results of a preemptive biomarker profiling program in relation to personalized clinical drug development at a large German Comprehensive Cancer Center
    In: Onkologie Jg. 35 (2012) Nr. Suppl. 6, S. 204 - 204

    • Abstracts

  • Oezkan, F.; Webendoerfer, M.; Winantea, Jane; Wiesweg, Marcel; Metzenmacher, M.; Theegarten, Dirk; Darwiche, Kaid; Bölükbas, S.; Dörr, F.; Taube, Christian; Stuschke, Martin; Opitz, Marcel; Schuler, Martin; Eberhardt, Wilfried
    Lung Cancer in Young Adults is Associated with Advanced Disease at Diagnosis and Increased Frequency of Targetable Mutations
    In: Journal of Thoracic Oncology Jg. 19 (2024) Nr. Suppl. 10, S. S84 - S85
  • Kersting, David; Sandach, Patrick; Sraieb, Miriam; Wiesweg, Marcel; Metzenmacher, Martin; Darwiche, Kaid; Özkan, Filiz; Bölükbas, Servet; Stuschke, Martin; Umutlu, Lale; Nader, Michael; Hamacher, Rainer; Fendler, Wolfgang; Wienker, Johannes; Eberhardt, Wilfried; Schuler, Martin; Herrmann, Ken; Hautzel, H.
    68Ga-SSO-120 versus 18F-FDG PET in the Initial Staging of Small-Cell Lung Cancer Patients
    In: European Journal of Nuclear Medicine and Molecular Imaging Jg. 50 (2023) Nr. Suppl. 1, Annual Congress of the European Association of Nuclear Medicine September 9–13, 2023 Vienna, Austria, S. 488 - S489
    Online Volltext: dx.doi.org/
  • Kersting, David; Sandach, Patrick; Sraieb, Miriam; Wiesweg, Marcel; Metzenmacher, Martin; Darwiche, Kaid; Oezkan, Filiz; Bolukbas, Servet; Stuschke, Martin; Umutlu, Lale; Nader, Michael; Fendler, Wolfgang; Wienker, Johannes; Eberhardt, Wilfried; Schuler, Martin; Herrmann, Ken; Hautzel, Hubertus
    68Ga-Satoreotide PET for Staging of Small-Cell Lung Cancer Patients
    In: Journal of Nuclear Medicine (JNM) Jg. 64 (2023) Nr. Suppl. 1, P165
  • Stickelmann, A.; Scharpenseel, H.; Siemanowski, J.; Noelle Thielert, Franziska; Wiesweg, Marcel; Nogova, L.; et al.;
    Clinical characteristics and treatment outcome of FGFR1-3 fusions in patients with non-small cell lung cancer (NSCLC) : A multicenter analysis from National Network Genomic Medicine
    Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie ; 13. bis 16. Oktober 2023, Hamburg, Germany,
    In: Oncology Research and Treatment Jg. 46 (2023) Nr. Supplement 5: DGHO Abstracts, S. 146 - 147
    Online Volltext: dx.doi.org/ (Open Access)
  • Kron, A.; Scheffler, M.; Wiesweg, Marcel; Hummel, H-D.; Kulhavy, J.; Gattenlöhner, S.; Kollmeier, J.; Schubart, C.; Gross, T.; Demes, M.; Keymel, S.; Joosten, M.; Merkelbach-Bruse, S.; Wölwer, C.; Oeser, K.; Zehaczek, M.; Jeratsch, U.; Wolf, J.;
    Efficacy of capmatinib compared to standard of care for German patients with locally advanced or metastatic NSCLC harboring METex14 mutations : Results from the RECAP study
    ESMO Congress 2023 ; 20 - 24 October 2023, Madrid, Spain,
    In: Annals of Oncology Jg. 34 (2023) Nr. Supplement 2: Abstract Book of the ESMO Congress 2023, 20 - 24 October 2023, S. S793 - S794
    Online Volltext: dx.doi.org/
  • Möhrmann, L.; Rostock, L.; Oles, M.; Wiesweg, Marcel; Glimm, H.; et al.; ; DKFZ/NCT/DKTK MASTER
    Genomics-based characterization and personalized therapy of advanced thymic epithelial tumors
    Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie ; 13. bis 16. Oktober 2023, Hamburg, Germany,
    In: Oncology Research and Treatment Jg. 46 (2023) Nr. Supplement 5: DGHO Abstracts, S. 144
    Online Volltext: dx.doi.org/ (Open Access)
  • Stockey, M.; Treckmann, Jürgen-Walter; Rink, A.; Schmidt, H.; Markus, Peter; Albers, David; Zaun, G.; Kostbade, K.; Hilser, T.; Pogorzeslki, M.; Baba, Hideo Andreas; Wiesweg, Marcel; Schuler, Martin; Kasper, Stefan; Virchow, I.;
    HER2-low as potential prognostic biomarker in patients (pts) with metastatic or recurrent Gastric Cancer (GC) or esophageal-gastric junction (AEG) adenocarcinoma
    Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie ; 13. bis 16. Oktober 2023, Hamburg, Germany,
    In: Oncology Research and Treatment Jg. 46 (2023) Nr. Supplement 5: DGHO Abstracts, S. 117 - 118
    Online Volltext: dx.doi.org/ (Open Access)
  • Richlitzki, Cedric; Pöttgen, Christoph; Wiesweg, Marcel; Metzenmacher, Martin; Guberina, Nika; Gauler, Thomas; Hautzel, Hubertus; Eberhardt, Wilfried; Darwiche, Kaid; Theegarten, Dirk; Bölükbas, Servet; Schuler, Martin; Stuschke, Martin; Guberina, Maja
    Kreuzvalidierte Prognoseparameter C-reaktives Protein und Blutbild-Parameter im Verlauf der kurativ intendierten Radiochemotherapie bei Patienten mit nichtkleinzelligem Lungenkarzinom (NSCLC) im Stadium IIIA-C
    In: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics Jg. 199 (2023) Nr. Suppl. 1, S. S100 - S101
    Online Volltext: dx.doi.org/ (Open Access)
  • Guberina, Maja; Pöttgen, Christoph; Wiesweg, Marcel; Metzenmacher, Martin; Richlitzki, Cedric; Plönes, Till; Guberina, Nika; Forsting, Michael; Herrmann, Ken; Gauler, Thomas; Hoffmann, Christian; Theegarten, Dirk; Darwiche, Kaid; Garcia, Alina Santiago; Stuschke, Martin; Schuler, Martin
    Long-term Survival in Patients with oligometastatic Lung Cancer (cT4 or cN2-3, cM1a-c) after thoracic Chemoradiation, Metastasis-directed and Systemic Therapy compared with the Outcome in locally advanced Lung Cancer (cT4 or cN2-3, cM0)
    In: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics Jg. 199 (2023) Nr. Suppl. 1, S. S101 - S102
    Online Volltext: dx.doi.org/
  • Schuler, Martin H. H.; Cuppens, K.; Ploenes, T.; Vanbockrijck, M.; Wiesweg, Marcel; Darwiche, Kaid; Schramm, Alexander; Maes, B.; Hegedus, B.; Schildhaus, Hans-Ulrich; Hautzel, H.; Theegarten, Dirk; Baas, P.; Hartemink, K.; Du Pont, B.; Aigner, Clemens;
    A randomized, multicentric phase II study of preoperative nivolumab plus relatlimab or nivolumab in patients with resectable non-small cell lung cancer (NEOpredict-Lung)
    ESMO Congress 2022, 9 - 13 September 2022, Paris, France,
    In: Annals of Oncology Jg. 33 (2022) Nr. Supplement 7: Abstract Book of the ESMO Congress 2022, 9 - 13 September 2022, S. S1404
    Online Volltext: dx.doi.org/ (Open Access)
  • Petzold, A.; Dujardin, P.; Oeck, S.; Wiesweg, Marcel; Hegedüs, B.; Schuler, Martin; Grüner, Barbara M.; Schramm, Alexander
    Combining Patient-Derived Xenografts and Barcoding Technology to Evaluate Response to Targeted Therapies in ALK+NSCLC
    In: Journal of Thoracic Oncology Jg. 17 (2022) Nr. 9, S. 611
    Online Volltext: dx.doi.org/
  • Guberina, M.; Pöttgen, Christoph; Guberina, N.; Gauler, Thomas; Metzenmacher, M.; Wiesweg, Marcel; Richlitzki, C.; Plönes, T.; Forsting, Michael; Wetter, Axel; Herrmann, Ken; Hautzel, H.; Darwiche, Kaid; Theegarten, Dirk; Aigner, Clemens; Schuler, Martin; Eberhardt, Wilfried E. E.; Stuschke, Martin;
    Robuste und lang-andauernde Wirksamkeit der Durvalumab-Konsolidierung bei NSCLC im Stadium III nach Induktionschemotherapie und definitiver Radiochemotherapie : Fokus auf Behandlungsauswahl und prognostische Faktoren
    28. Kongress der Deutschen Gesellschaft für Radioonkologie ; DEGRO 2022 ; 26. bis 28.05.2022, Stuttgart, Germany,
    In: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics Jg. 198 (2022) Nr. Supplement 1, S. S15
    Online Volltext: dx.doi.org/ (Open Access)
  • Tüns, A.I.; Ho, C.S.L.; Schildhaus, Hans-Ulrich; Wiesweg, Marcel; Grüner, Barbara M.; Hegedüs, B.; Schuler, Martin; Schramm, Alexander; Oeck, S.
    Targeting SHP2 Reverts Oncogenic Mediated Resistance to KRAS-G12C Inhibition
    In: Journal of Thoracic Oncology Jg. 17 (2022) Nr. 9, S. S586 - S587
    Online Volltext: dx.doi.org/
  • Guberina, M.; Herrmann, Ken; Pöttgen, Christoph; Guberina, N.; Hoffmann, C.; Ploenes, T.; Gauler, Thomas; Wetter, Axel; Umutlu, Lale; Hautzel, H.; Theegarten, Dirk; Schuler, Martin; Eberhardt, Wilfried; Metzenmacher, M.; Wiesweg, Marcel; Aigner, Clemens; Darwiche, Kaid; Karpf-Wissel, Rüdiger; Stuschke, Martin
    EBUS-TBNA and [F-18] FDG-PET/CT for precise Target Volume Definition prior to Chemoradiotherapy : Lymphonodular Spreading Patterns in Stage III NSCLC
    In: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics Jg. 197 (2021) Nr. Suppl. 1, S. 142
  • Pöttgen, Christoph; Gauler, Thomas; Guberina, M.; Pierscianek, D.; Wrede, Karsten; Wiesweg, Marcel; Eberhardt, Wilfried; Schuler, Martin; Stuschke, Martin
    Re-Irradiation of cerebral Metastases after prophylactic Brain Skull irradiation in small-cell neuroendocrine Lung Cancer (SCLC)
    In: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics Jg. 197 (2021) Nr. Suppl. 1, S. 176
  • Janning, M.; Süptitz, J.; Wiesweg, Marcel; Schildhaus, Hans-Ulrich; Loges, S.; ; et al.; Nationales Netzwerk Genomische Medizin
    Response to treatment of uncommon EGFR mutations : a retrospective analysis from the German National Network Genomic Medicine Lung Cancer (nNGM)
    Gemeinsame Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie ; 01.-04. Oktober 2021, Hybrid-Kongress,
    In: Oncology Research and Treatment Jg. 44 (2021) Nr. Supplement 2, S. 3 - 4
    Online Volltext: dx.doi.org/ (Open Access)
  • Janning, Melanie; Sueptitz, Juliane; Forstreuter, Anika; Albers-Leischner, Corinna; Tufman, Amanda; Velthaus-Rusik, Janna-Lisa; Reck, Martin; Jung, Andreas; Bonzheim, Irina; Brändlein, Stephanie; Wiesweg, Marcel; Stratmann, Jan; Alt, Juergen; Limberg, Juliane; Saalfeld, Felix Carl; Berger, Johannes; Tögel, Lars; Buettner, Reinhard; Wolf, Juergen; Loges, Sonja
    Treatment outcome and functional characterization of uncommon EGFR mutations in the German National Network Genomic Medicine Lung Cancer (nNGM)
    In: Journal of Clinical Oncology (JCO) Jg. 39 (2021) Nr. 15_Suppl, S. 9036 - 9036
    Online Volltext: dx.doi.org/
  • Kraskowski, O.; Eberhardt, Wilfried; Metzenmacher, Martin; Zaun, Gregor; McCutcheon, A.; Schmid, Kurt Werner; Schildhaus, Hans-Ulrich; Darwiche, Kaid; Aigner, Clemens; Kasper, Stefan; Hense, Jörg; Gruenwald, Viktor; Wiesweg, Marcel; Schuler, Martin; Pogorzelski, Michael;
    Patients with metastatic EGFR-mutated non-small cell lung cancer (NSCLC) show highly favorable outcomes with treatment sequences provided at a comprehensive cancer center
    Virtuelle Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie, 09.–11. Oktober 2020,
    In: Oncology Research and Treatment Jg. 43 (2020) Nr. Suppl. 4, S. 137
    Online Volltext: dx.doi.org/ (Open Access)
  • Darwiche, Kaid; Theegarten, Dirk; Schildhaus, Hans-Ulrich; Schuler, Martin; Wiesweg, Marcel; Aigner, Clemens; Karpf-Wissel, Rüdiger
    The impact of needle choice on molecular analysis of ultrasound-guided transbronchial needle aspiration (EBUS-TBNA) in NSCLC
    In: European Respiratory Journal (ERJ) Jg. 56 (2020) Nr. Suppl. 64,
    Online Volltext: dx.doi.org/
  • Bogner, Simon; Schmid, Kurt Werner; Metzenmacher, Martin; Hager, Thomas; Herrmann, Ken; Walter, Robert; Hegedues, Balazs; Herold, Thomas; Eberhardt, Wilfried; Reis, Henning; Goetz, Moritz; Mairinger, Fabian Dominik; Wiesweg, Marcel; Darwiche, Kaid; Aigner, Clemens; Schuler, Martin
    Development of predictors for PD-1/PD-L1-directed therapy of non-small cell lung cancer (NSCLC) by gene expression profiling of small diagnostic biopsies (DBX)
    In: Journal of Clinical Oncology (JCO) Jg. 36 (2018) Nr. 15 Suppl., S. e15121
    Online Volltext: dx.doi.org/ (Open Access)
  • Cao, J.; Wiesweg, Marcel; Fuchs, M.; Stein, A.; Karthaus, M.; Lettmaier, S.; Kretzschmar, A.; Draube, A.; Ettrich, T.; Rüssel, J.; Müller, C.; Rafiyan, M.-R.; Borchert, K.; Schuler, Martin; Kasper, Stefan;
    Efficacy and safety of Trifluridin/Tipiracil (FTD/TPI) (Lonsurf (R)) in patients with metastatic colorectal cancer (CRC) in clinical-routine use
    Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie ; 28. September - 2. Oktober 2018, Wien,
    In: Oncology Research and Treatment Jg. 41 (2018) Nr. Suppl. 4, S. 289
    Online Volltext: dx.doi.org/ (Open Access)
  • Reis, Henning; Niedworok, Christian; Wiesweg, Marcel; Schuler, Martin; Rübben, Herbert; Hadaschik, Boris; Schmid, Kurt Werner; Szarvas, Tibor;
    Potentially Targetable Molecular Alterations in 70 Cases of Urachal Cancer
    Geared to Learn ; USCAP 107th Annual Meeting ; March 17–23, 2018, Vancouver,
    In: Modern Pathology Jg. 31 (2018) Nr. Suppl. 2, S. 378
    Online Volltext: dx.doi.org/ (Open Access)
  • Wiesweg, Marcel;
    Predictive markers for immune checkpoint inhibitor therapy
    Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie ; 28. September - 2. Oktober 2018, Wien,
    In: Oncology Research and Treatment Jg. 41 (2018) Nr. Suppl. 4, S. 12
    Online Volltext: dx.doi.org/ (Open Access)
  • Wiesweg, Marcel; Reis, Henning; Köster, T.; Goetz, M.; Worm, K.; Herold, T.; Paul, Andreas; Dechene, Alexander; Schumacher, B.; Markus, P.; Virchow, I.; Kostbade, K.; Wolf, N.; Zaun, G.; Metzenmacher, M.; Schmid, Kurt Werner; Schuler, Martin; Kasper, Stefan;
    Signaling network activation in colorectal cancer : p70S6K phosphorylation as a prognostic marker
    33. Deutscher Krebskongress - Perspektiven verändern Krebs - Krebs verändert Perspektiven. Diagnose - Therapie - (Über-)Leben ; 21.-24. Februar 2018, Berlin,
    In: Oncology Research and Treatment Jg. 41 (2018) Nr. Suppl. 1, S. 55
    Online Volltext: dx.doi.org/ (Open Access)
  • Richly, Heike; Scheulen, Max Ernst; Wiesweg, Marcel; Abendroth, A.; Schuler, Martin; Bauer, Sebastian;
    Systemic treatment of metastatic uveal melanoma - a silver lining on the horizon?
    31. Deutscher Krebskongress iKON - intelligente Konzepte in der Onkologie, 19.-22. Februar 2014, Berlin, Germany,
    In: Oncology Research and Treatment Jg. 37 (2014) Nr. Suppl. 1, 31. Deutscher Krebskongress iKON - intelligente Konzepte in der Onkologie Berlin, 19.-22. Februar 2014: Abstracts, S. 118 - 119
    Online Volltext: dx.doi.org/
  • Nogova, L.; Gardizi, M.; Bos, M.; Scheffler, M.; Papachristou, I.; Wompner, C.; Heukamp, L.; Schildhaus, H. U.; Fuhr, U.; Sos, M.; Eberhardt, Wilfried; Wiesweg, Marcel; Schmid, Kurt Werner; Schuler, Martin; Thomas, R.; Buttner, R.; Wolf, J.;
    TRY : A phase II study to evaluate safety and efficacy of combined trastuzumab and AUY922 in advanced non-small-cell lung cancer (NSCLC) with HER2 overexpression or amplification or mutation
    31. Deutscher Krebskongress iKON - intelligente Konzepte in der Onkologie, 19.-22. Februar 2014, Berlin,
    In: Oncology Research and Treatment Jg. 37 (2014) Nr. Suppl. 1, S. 92
    Online Volltext: dx.doi.org/
  • Nogova, Lucia; Gardizi, Masyar; Bos, Marc Christiaan Allardt; Scheffler, Matthias; Mattonet, Christian; Heukamp, Lukas Carl; Schildhaus, Hans-Ulrich; Fuhr, Uwe; Eberhardt, Wilfried; Reis, Henning; Wiesweg, Marcel; Schmid, Kurt Werner; Schoch, Gernot; Ko, Yon-Dschun; Serke, Monika Heidi; Schuler, Martin H.; Büttner, Reinhard; Wolf, Jürgen
    TRY : A phase II study to evaluate safety and efficacy of combined trastuzumab and AUY922 in advanced non-small cell lung cancer (NSCLC) with HER2 overexpression or amplification or mutation
    In: Journal of Clinical Oncology (JCO) Jg. 32 (2014) Nr. 15, Suppl., S. 8109
    Online Volltext: dx.doi.org/
  • Wiesweg, Marcel; Ting, Saskia; Reis, Henning; Worm, K.; Kasper, Stefan; Bauer, Sebastian; Gauler, Thomas; Welt, Anja; Richly, Heike; Tewes, Mitra; Meiler, Johannes; Hense, Jörg; Eberhardt, Wilfried; Derks, Christian; Cortes-Incio, D.; Skottky, S.; Wohlschläger, Jeremias; Breitenbucher, F.; Freitag, Lutz; Stamatis, Georgios; Schmid, Kurt Werner; Schuler, Martin;
    WTZ-Tumorprofil-A preemptive biomarker profiling program in relation to personalized clinical drug development at a large German Comprehensive Cancer Center : Two years experience
    31. Deutscher Krebskongress iKON - intelligente Konzepte in der Onkologie, 19.-22. Februar 2014, Berlin, Germany,
    In: Oncology Research and Treatment Jg. 37 (2014) Nr. Suppl. 1, S. 2 - 3
    Online Volltext: dx.doi.org/
  • Abendroth, A.; Abramczyk, M.; Paul, Andreas; Gerken, Guido; Schmid, Kurt Werner; Markus, P.; Meiler, Johannes; Tometten, M.; Wiesweg, Marcel; Kaiser, Gernot Maximil; Dechene, Alexander; Trarbach, Tanja; Schuler, Martin; Kasper, Stefan;
    Outcome of patients (pts) with advanced pancreaticobiliary cancers treated with sequential chemotherapies at the West German Cancer Center (WTZ), one of the 11 Oncology Centers of Excellence in Germany
    17 Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Onkologie, 18.-22. Oktober 2013, Wien, Österreich,
    In: Onkologie Jg. 36 (2013) Nr. Suppl. 7, S. 263
    Online Volltext: dx.doi.org/
  • Nogova, L.; Gardizi, M.; Bos, MCA; Scheffler, M.; Papachristou, I.; Wompner, C.; Heukamp, L. C.; Schildhaus, H. U.; Fuhr, U.; Sos, M. L.; Eberhardt, Wilfried; Wiesweg, Marcel; Schmid, Kurt Werner; Schuler, Martin; Thomas, R. K.; Buttner, R.; Wolf, J.
    TRY : A phase II study to evaluate safety and efficacy of combined trastuzumab and AUY922 in advanced non-small-cell lung cancer (NSCLC) with HER2 overexpression or amplification or mutation
    In: Onkologie Jg. 36 (2013) Nr. Suppl. 7, S. 30
    Online Volltext: dx.doi.org/
  • Nogova, L.; Bos, M.; Gardizi, M.; Scheffler, M.; Papachristou, I.; Wompner, C.; Heukamp, L. C.; Schildhaus, H.; Fuhr, U.; Sos, M. L.; Eberhardt, Wilfried; Wiesweg, Marcel; Schmid, Kurt Werner; Schuler, Martin; Buttner, R.; Wolf, J.
    Try : a phase II study to evaluate safety and efficacy of combined trastuzumab and AUY922 in advanced non-small-cell lung cancer (NSCLC) with HER2 overexpression or amplification or mutation
    In: Journal of Thoracic Oncology Jg. 8 (2013) Nr. Suppl. 2, S. S914 - S915
    Online Volltext: dx.doi.org/ (Open Access)

    • Poster / Posterbeiträge

  • Wiesweg, Marcel; Küter, C.; Schnorbach, J.; Keyl, J.; Plönes, T.; Metzenmacher, M.; Cvetkovic, J.; Eberhardt, Wilfried E.E.; Oezkan, F.; Theegarten, Dirk; Stenzinger, A.; Darwiche, Kaid; Herth, F.J.F.; Bölükbas, S.; Winter, H.; Weykamp, F.; Stuschke, Martin; Thomas, M.; Schuler, Martin H. H.; Christopoulos, P.;
    Oligometastatic non-small cell lung cancer : Impact of local and systemic treatment approaches on clinical outcome
    ESMO Congress 2023 ; 20 - 24 October 2023, Madrid, Spain,
    In: Annals of Oncology Jg. 34 (2023) Nr. Supplement 2: Abstract Book of the ESMO Congress 2023, 20 - 24 October 2023, S. S828
    Online Volltext: dx.doi.org/
  • Reitnauer, L.; Evers, G.; Christoph, Daniel; Wiesweg, Marcel; Glanemann, Franziska; Webendörfer, Maximilian P.; Bleckmann, A.; et al.;
    Relapse after radiochemotherapy and consolidative Durvalumab in Stage III NSCLC – a retrospective analysis in a real-world setting
    Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie ; 13. bis 16. Oktober 2023, Hamburg, Germany,
    In: Oncology Research and Treatment Jg. 46 (2023) Nr. Supplement 5: DGHO Abstracts, S. 229
    Online Volltext: dx.doi.org/ (Open Access)
  • Saalfeld, F.C.; Möller, J.; Michels, S.; Grohe, C.; Wiesweg, Marcel; Schubart, C.; Alt, J.; Griesinger, F.; Kauffmann-Guerrero, D.; Kulhavy, J.; Overbeck, T.R.; Pelusi, N.; Rohde, G.; Wesseler, C.; Vathiotis, I.; Veluswamy, R.; Illini, O.M.; Rothschild, S.I.; Christopoulos, P.; Wermke, M.;
    Small cell transformation in EGFR-mutated non-small cell lung cancer (EGFR+ NSCLC) : Efficacy of immune checkpoint inhibitors or tyrosine kinase inhibitors combined with platinum-based chemotherapy
    ESMO Congress 2023 ; 20 - 24 October 2023, Madrid, Spain,
    In: Annals of Oncology Jg. 34 (2023) Nr. Supplement 2: Abstract Book of the ESMO Congress 2023, 20 - 24 October 2023, S. S770
    Online Volltext: dx.doi.org/ (Open Access)